Pfizer | Bienes



Assets Cambio Fecha
AbbVie USD 135.16B 8.26B 2024-12
Abbott USD 81.41B 7.06B 2024-12
ALKERMES USD 2.06B 99.72M 2024-12
Amgen USD 91.84B 956M 2024-12
AstraZeneca USD 104.04B 887M 2024-12
Bayer EUR 110.85B 3.9B 2024-12
Biogen USD 28.05B 263.9M 2024-12
Bristol-Myers Squibb USD 92.6B 1.07B 2024-12
Drreddys Laboratories INR 481.06B 15.1B 2024-12
Eli Lilly USD 78.71B 3.11B 2024-12
Gilead Sciences USD 59B 4.47B 2024-12
GlaxoSmithKline GBP 59.46B 1.41B 2024-12
Glaxosmithkline GBP 59.46B 1.41B 2024-12
Indivior 1.46B 71M 2024-09
J&J USD 180.1B 1.82B 2024-12
Medtronic USD 89.97B 69M 2025-01
Merck USD 117.11B 426M 2024-12
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Novartis USD 102.25B 1.28B 2024-12
Pacira USD 1.55B 31.82M 2024-12
Perrigo USD 9.65B 1.56B 2024-12
Pfizer USD 213.4B 6.08B 2024-12
Prestige Brands USD 3.33B 12.61M 2024-12
Regeneron Pharmaceuticals USD 37.76B 317.5M 2024-12
Roche Holding CHF 101.8B 6.02B 2024-12
Sanofi 129.76B 3.29B 2024-06
Sanofi 129.76B 3.29B 2024-06
Vertex Pharmaceuticals USD 22.53B 293M 2024-12
Zoetis USD 14.24B 120M 2024-12



Pfizer Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.